Optimizing Nebulised mRNA-LNP Delivery for Pulmonary Therapeutics and Clinical Translation

✨ Driving #MedTech innovation through cross-sector collaboration as part of the Australian Government Department of Education's National Industry PhD Program

🫁 An excit
ing new partnership between University of Melbourne and Misti aims to revolutionise the treatment of #Respiratory disease by refining a smart inhaler to deliver biological therapies to the lungs. This project builds on the #MedMisti prototype developed by the start-up company Misti, enhancing its ability to deliver biologics safely and effectively. By providing access to hospital-grade care at home, this purpose-driven innovation works towards #GlobalHealthEquity, empowering people to take an active role in their wellbeing.

👥 Bringing together clinical, academic and engineering expertise, this work is powered by a team of change-makers led by Industry PhD Candidate Breana Galea. During this project, Breana will receive mentorship and guidance from an interdisciplinary group of world-leading experts:

- Professor Bruce Thompson AM, clinician-scientist from the University of Melbourne who heads the Melbourne School of Health Sciences
- Dr. Anushi (Kulasiri) Rajapaksa, entrepreneur and biomedical engineer who founded and leads Misti
- Dr Ricky Theodore Tjeung, engineering and product development lead with the Melbourne Centre for Nanofabrication

🌱 This project has a clear translational pathway with the core goal of creating tangible impact for people living with respiratory conditions. Congratulations to all involved and the best of luck!

Previous
Previous

Developing AI-driven tools to maintain data standards and empirically validate investment outcomes for the managed accounts sector

Next
Next

A novel non-surgical bracing intervention to facilitate anterior cruciate ligament (ACL) healing after rupture